Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency - Related Studies

Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency

This study has been terminated.

Study NCT00004386. Last updated on June 23, 2005. Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Deficiency Diseases
		Ornithine Carbamoyltransferase Deficiency Disease

2	More general conditions related to this trial
		Amino Acid Metabolism, Inborn Errors
		Brain Diseases
		Brain Diseases, Metabolic
		Brain Diseases, Metabolic, Inborn
		Central Nervous System Diseases
		Genetic Diseases, Inborn
		Malnutrition
		Metabolic Diseases
		Metabolism, Inborn Errors
		Nervous System Diseases
		Nutrition Disorders

3	Sponsors listed in this trial
		Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
		Childrens Research Institute